Search results

Showing 1 - 10 of 54 results

Sort results by: date | relevance

1 2 3 4 5 ...

Search filters:

By Date

  • 2000 Remove filter

By Industry Sector

  • Healthcare. Remove filter

Click remove filters icon to remove filters

Clear this search

Add Search Filters:

By Publication

By Industry Sector

NEWS BRIEFS

CORRECTIONS:

International News: UK court rules on Viagra patent, rivals to scramble

LONDON: The blueprint for anti-impotence drugs such as Viagra is up for grabs in the UK, where a court last week stripped Pfizer of its patent on the drug's design.

Last Call: Colle & McVoy press releases are going to the dogs

Colle & McVoy Marketing Communications, which earlier this year began offering pet insurance to its employees (PRWeek, June 19, 2000), is up to its old furry friends-loving tricks again. This time, the funky Minneapolis agency has used trained dogs to deliver press releases for client Pfizer Animal...

Voluntary PPA drug recall

WASHINGTON: Drug companies have moved to reassure consumers by voluntarily removing products containing phenylpropanolamine (PPA) from stores. This despite the fact that some believe the ingredient is not a risk when used correctly.

Merck hires a VP from government

WHITEHOUSE STATION, NJ: A former US Social Security Administration deputy commissioner has been hired by pharmaceutical giant Merck as corporate communications VP.

MS&L hires a VP to push Celebrex

NEW YORK: Manning, Selvage & Lee has hired Harriet Shelare as VP to handle the weighty task of media relations for Pharmacia's blockbuster arthritis drug, Celebrex.

CAMPAIGNS: Product PR - Hair-care client scores with Joe

Client: Just For Men Haircolor (White Plains, NY)

EDITORIAL: How to market a controversial pill

The FDA s recent approval of the abortion pill mifepristone, more commonly known as RU-486, brings with it several important communications issues, the least of which is the never-ending debate over abortion itself.

THE BIG PITCH: How would you market for or against the abortion drug Mifeprex aka RU-486?

KRISTIN HANSEN, Media Director, Family Research Council

Marketing of RU-486 begins quietly at DDB

PR agency DDB Issues & Advocacy was hired earlier this year to campaign for a favorable FDA decision and on the agency's approval of US sale of the pill, to market it to healthcare professionals, said DDB senior vice president Arlene Fairfield. Fairfield, in charge of a six-member PR team spread...

1 2 3 4 5 ...

Additional Information

Campaign Jobs



Mobile

Making the most of mobile

Welcome to the first incarnation of a new element in Campaign in which we invite experts to burrow beneath the surface of the catch-all that is "digital". Google, Isobar Mobile, JWT London, LBI and MBA share their insights on mobile.